LeMaitre to Present at the Canaccord Genuity 42nd Annual Growth Conference

LeMaitre Vascular (Nasdaq:LMAT) announced that CFO JJ Pellegrino will present at the Canaccord Genuity 42nd Annual Growth Conference on August 11, 2022, at 12:00 PM ET in Boston.

Rhea-AI Impact

(Neutral)

Rhea-AI Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Rhea-AI Summary

LeMaitre Vascular (Nasdaq:LMAT) announced that CFO JJ Pellegrino will present at the Canaccord Genuity 42nd Annual Growth Conference on August 11, 2022, at 12:00 PM ET in Boston. The company focuses on devices, implants, and services for treating peripheral vascular disease, affecting over 200 million people globally. LeMaitre develops and markets vascular devices aimed at the needs of vascular surgeons. For more details, visit lemaitre.com.

Argus Session date unavailable

-0.73% session move Open Argus

Details

News Market Reaction – LMAT

The recorded move for LMAT in the trading session of this news was -0.73%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

08/01/2022 - 04:25 PM

BURLINGTON, Mass., Aug. 01, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the Canaccord Genuity 42^nd Annual Growth Conference on Thursday, August 11, 2022, at 12:00 PM ET at the InterContinental Hotel, Boston.

About LeMaitre

LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will LeMaitre Vascular present at the Canaccord Genuity Conference?

LeMaitre Vascular will present at the Canaccord Genuity 42nd Annual Growth Conference on August 11, 2022, at 12:00 PM ET.

Who is presenting for LeMaitre Vascular at the conference?

JJ Pellegrino, the Chief Financial Officer, will present for LeMaitre Vascular.

What is the primary focus of LeMaitre Vascular?

LeMaitre Vascular specializes in devices, implants, and services for the treatment of peripheral vascular disease.

How many people worldwide are affected by peripheral vascular disease?

Peripheral vascular disease affects more than 200 million people globally.

Where is the Canaccord Genuity Conference being held?

The conference is taking place at the InterContinental Hotel in Boston.

Keep reading

Trending in the feed

RDW

Sophia Space and Redwire Team Up to Advance Orbital Data Center Infrastructure Open the live feed